Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
3.69K
-
Shares change
-
-37.4M
-
Total reported value, excl. options
-
$2.84K
-
Value change
-
-$28.9M
-
Number of sells
-
-54
-
Price
-
$0.77
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2024
56 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q4 2024.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.69K shares
of 7.23M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include Marquette Asset Management, LLC (0 shares), Global Retirement Partners, LLC (0 shares), RETIREMENT CAPITAL STRATEGIES (0 shares), AMUNDI (0 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (0 shares), BlackRock, Inc. (0 shares), RVW Wealth, LLC (0 shares), Qiming U.S. Ventures Management, LLC (0 shares), AVANTAX ADVISORY SERVICES, INC. (0 shares), and Acuitas Investments, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.